ProMIS Neurosciences PMN
NASDAQ PMN
$14.51 -0.40 (-2.68%)
As of: Aug 21, 2026 · 3:59 PM EDT

ProMIS Neurosciences (PMN) Other Non Operating Income (2021 - 2026)

ProMIS Neurosciences' (PMN) quarterly Other Non Operating Income came in at $400523.0 in Q1 2026, up 257.0% YoY from $112192.0 in Q1 2025, and up 333.28% on a QoQ basis from $92439.0 in Q4 2025.

ProMIS Neurosciences (PMN) Other Non Operating Income (2021 - 2026) Analysis & Trends

ProMIS Neurosciences (PMN) has 6 years of Other Non Operating Income data on file, last reported at $400523.0 in Q1 2026.

  • Quarterly Other Non Operating Income rose 257.0% year-over-year to $400523.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $730900.0 (up 20.63% YoY) and the FY2025 annual result came in at $442569.0, down 29.32% from the prior year.
  • Other Non Operating Income grew to $400523.0 in Q1 2026, from $92439.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $400523.0 in Q1 2026 to a low of $10774.0 in Q1 2022.
  • A 5-year average of $115864.9 and a median of $92439.0 in 2025 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2022 — Other Non Operating Income soared 5174.14% — and 2025, when it tumbled 59.25%.
  • Tracing PMN's Other Non Operating Income over 5 years: stood at $52610.0 in 2022, then soared by 257.03% to $187833.0 in 2023, then climbed by 20.77% to $226840.0 in 2024, then plunged by 59.25% to $92439.0 in 2025, then soared by 333.28% to $400523.0 in 2026.
  • The last three Other Non Operating Income figures came in at $400523.0 (Q1 2026), $92439.0 (Q4 2025), and $170306.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 ProMIS Neurosciences 132.34 Mn 78.87 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 536,743.00
Mar 31, 2026 400,523.00
Dec 31, 2025 92,439.00
Sep 30, 2025 170,306.00
Jun 30, 2025 67,632.00
Mar 31, 2025 112,192.00
Dec 31, 2024 226,840.00
Sep 30, 2024 235,912.00
Jun 30, 2024 30,962.00
Mar 31, 2024 132,470.00
Dec 31, 2023 187,833.00
Sep 30, 2023 113,286.00
Jun 30, 2023 30,878.00
Mar 31, 2023 52,905.00
Dec 31, 2022 52,610.00
Sep 30, 2022 35,853.00
Jun 30, 2022 16,288.00
Mar 31, 2022 10,774.00
Dec 31, 2021 11,236.00
Sep 30, 2021 4,052.00